Clinical Trial Update: Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy

View source ↗

Summary

This clinical trial update investigates serum miR-122 as a real-time biomarker for detecting drug-induced liver injury in patients undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Drug-induced Liver Injury

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Chemotherapeutic Toxicity, Malignant Tumor | Status: UNKNOWN